Total Payments
$205,196
2024 Payments
$23,874
Companies
42
Transactions
501
Medicare Patients
3,004
Medicare Billing
$380,024
Payment Breakdown by Category
Other$113,111 (55.1%)
Consulting$67,441 (32.9%)
Travel$14,170 (6.9%)
Food & Beverage$9,868 (4.8%)
Education$605.43 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $113,111 | 39 | 55.1% |
| Consulting Fee | $67,441 | 24 | 32.9% |
| Travel and Lodging | $14,170 | 54 | 6.9% |
| Food and Beverage | $9,868 | 381 | 4.8% |
| Education | $605.43 | 3 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Covidien LP | $90,613 | 70 | $0 (2020) |
| Ethicon US, LLC | $39,202 | 28 | $0 (2020) |
| Medical Device Business Services, Inc. | $24,178 | 39 | $0 (2023) |
| Ferring Pharmaceuticals Inc. | $19,897 | 29 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $13,588 | 34 | $0 (2024) |
| Ethicon Inc. | $9,808 | 7 | $0 (2019) |
| Medtronic, Inc. | $2,721 | 3 | $0 (2023) |
| ABBVIE INC. | $2,466 | 148 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $473.15 | 34 | $0 (2024) |
| PFIZER INC. | $283.39 | 18 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $23,874 | 121 | Phathom Pharmaceuticals, Inc. ($13,588) |
| 2023 | $23,154 | 87 | Ferring Pharmaceuticals Inc. ($11,029) |
| 2022 | $8,519 | 48 | Medical Device Business Services, Inc. ($7,680) |
| 2021 | $878.46 | 35 | Medtronic, Inc. ($425.00) |
| 2020 | $19,102 | 18 | Covidien LP ($12,358) |
| 2019 | $60,650 | 94 | Ethicon US, LLC ($34,850) |
| 2018 | $21,602 | 37 | Covidien LP ($20,290) |
| 2017 | $47,415 | 61 | Covidien LP ($46,780) |
All Payment Transactions
501 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/17/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/17/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: Gastroenterology | ||||||
| 12/17/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $8.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/17/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $6.19 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/16/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: Immunology | ||||||
| 12/12/2024 | ABBVIE INC. | VIBERZI (Drug), CREON | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/06/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: ONCOLOGY | ||||||
| 12/05/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: Gastroenterology | ||||||
| 12/04/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Travel and Lodging | Cash or cash equivalent | $135.34 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/02/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: LIVER DISEASE | ||||||
| 11/21/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $10.47 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/15/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: LIVER DISEASE | ||||||
| 11/14/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,150.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/14/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $13.05 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/12/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: ONCOLOGY | ||||||
| 11/08/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Travel and Lodging | In-kind items and services | $163.24 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/08/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $113.48 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $22.33 | General |
| Category: Immunology | ||||||
| 11/04/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 10/31/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 766 | 835 | $505,981 | $99,531 |
| 2022 | 14 | 788 | 847 | $617,771 | $102,373 |
| 2021 | 16 | 703 | 732 | $522,245 | $93,190 |
| 2020 | 19 | 747 | 834 | $489,646 | $84,930 |
Total Patients
3,004
Total Services
3,248
Medicare Billing
$380,024
Procedure Codes
64
All Medicare Procedures & Services
64 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 171 | 171 | $73,017 | $22,726 | 31.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 183 | 223 | $61,481 | $22,173 | 36.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 52 | 52 | $99,312 | $11,766 | 11.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 66 | 67 | $71,653 | $9,297 | 13.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 59 | 63 | $21,756 | $7,041 | 32.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 71 | 73 | $73,600 | $6,111 | 8.3% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 28 | 28 | $23,240 | $5,586 | 24.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 27 | 48 | $9,391 | $3,292 | 35.1% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 26 | 26 | $24,565 | $2,302 | 9.4% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 11 | 11 | $9,994 | $2,198 | 22.0% |
| 45330 | Diagnostic exam of lower portion of large bowel using a flexible endoscope | Office | 2023 | 12 | 12 | $3,176 | $1,929 | 60.7% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 11 | 12 | $23,280 | $1,596 | 6.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 15 | 15 | $4,495 | $1,299 | 28.9% |
| 91010 | Study of esophagus to assess movement | Facility | 2023 | 21 | 21 | $4,242 | $1,167 | 27.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 13 | 13 | $2,779 | $1,047 | 37.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 218 | 266 | $63,574 | $28,625 | 45.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 177 | 177 | $64,959 | $22,881 | 35.2% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 61 | 61 | $170,556 | $13,053 | 7.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 81 | 81 | $101,655 | $11,374 | 11.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 77 | 79 | $63,200 | $6,383 | 10.1% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 16 | 16 | $16,736 | $3,271 | 19.5% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 21 | 21 | $43,764 | $3,198 | 7.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 14 | 16 | $7,072 | $2,761 | 39.0% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 27 | 27 | $5,967 | $2,358 | 39.5% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 23 | 23 | $39,445 | $1,960 | 5.0% |
About Dr. Anish Sheth, MD
Dr. Anish Sheth, MD is a Gastroenterology healthcare provider based in Princeton, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1336235191.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anish Sheth, MD has received a total of $205,196 in payments from pharmaceutical and medical device companies, with $23,874 received in 2024. These payments were reported across 501 transactions from 42 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($113,111).
As a Medicare-enrolled provider, Sheth has provided services to 3,004 Medicare beneficiaries, totaling 3,248 services with total Medicare billing of $380,024. Data is available for 4 years (2020–2023), covering 64 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Princeton, NJ
- Active Since 10/05/2006
- Last Updated 03/12/2015
- Taxonomy Code 207RG0100X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1336235191
Products in Payments
- LINX Reflux Management System (Device) $56,950
- Barrx (Device) $47,385
- REBYOTA (Biological) $19,750
- VOQUEZNA (Drug) $13,588
- PillCam (Device) $7,558
- Bravo (Device) $4,861
- Manometry (Device) $3,176
- SKYRIZI (Biological) $762.83
- RINVOQ (Biological) $717.40
- Humira (Biological) $415.82
- HUMIRA (Biological) $378.09
- XIFAXAN (Drug) $368.89
- XELJANZ (Drug) $250.75
- DUPIXENT (Biological) $195.72
- ENTYVIO (Biological) $183.19
- STELARA (Biological) $183.03
- IBSRELA (Drug) $170.61
- Linzess (Drug) $120.98
- LINX (Device) $113.54
- ESOPHYX (Device) $102.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Princeton
Amy Shriver, M.d, M.D
Gastroenterology — Payments: $86,913
Gastroenterology $86,913
Glenn Osias, Md, MD
Gastroenterology — Payments: $13,027
Gastroenterology $13,027
Aaron Bellows, M.d, M.D
Gastroenterology — Payments: $7,850
Gastroenterology $7,850
Robert Meirowitz, Md, MD
Gastroenterology — Payments: $7,725
Gastroenterology $7,725
Aloysius Rho, Md, MD
Gastroenterology — Payments: $7,329
Gastroenterology $7,329
Dr. Darren Andrade, M.d, M.D
Gastroenterology — Payments: $5,859
Gastroenterology $5,859